OrbiMed Israel GP II, L.P.
Insider CIK 1682090 · STDY 10% owner · LOGC Director, 10% owner · ACET Director, 10% owner · ETNB Director, 10% owner · GLTO Director, 10% owner · ADRX Director, 10% owner · UPB Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 2,000,962 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 769,601 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 564,187 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 7,127,019 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 1,333,975 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 513,067 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 10,690,530 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 256,448 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 588,235 | $17.00 | $10.00M | 588,235 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 61,516 | $17.00 | $1.05M | 9,292,025 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 10,690,530 | — | $0 | 10,690,530 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 2,000,962 | — | $0 | 12,691,492 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 769,601 | — | $0 | 13,461,093 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 256,448 | — | $0 | 9,230,509 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 513,067 | — | $0 | 8,974,061 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 1,333,975 | — | $0 | 8,460,994 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 7,127,019 | — | $0 | 7,127,019 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 300,249 | $17.00 | $5.10M | 14,325,529 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 564,187 | — | $0 | 14,025,280 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 256,448 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 513,067 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 1,333,975 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 7,127,019 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 564,187 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 769,601 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 2,000,962 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 10,690,530 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 588,235 | $17.00 | $10.00M | 588,235 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 61,516 | $17.00 | $1.05M | 9,292,025 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 256,448 | — | — | 9,230,509 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 513,067 | — | — | 8,974,061 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 1,333,975 | — | — | 8,460,994 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 7,127,019 | — | — | 7,127,019 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 300,249 | $17.00 | $5.10M | 14,325,529 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 564,187 | — | — | 14,025,280 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 769,601 | — | — | 13,461,093 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 2,000,962 | — | — | 12,691,492 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 10,690,530 | — | — | 10,690,530 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-08 | 2026-04-09 | 40,416 | $6.52 | $263.5K | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-08 | 2026-04-09 | 32,523 | $6.29 | $204.6K | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-07 | 2026-04-09 | 2,400 | $6.38 | $15.3K | 32,523 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-07 | 2026-04-09 | 29,319 | $6.53 | $191.5K | 34,923 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2025-10-08 | 2025-10-10 | 3,500,000 | $1.00 | $3.50M | 4,490,254 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2025-10-08 | 2025-10-10 | 1,500,000 | $1.00 | $1.50M | 9,026,359 | SEC↗ |
| UPB Upstream Bio, Inc. | C Conversion deriv | 2024-10-15 | 2024-10-17 | 524,500 | — | $0 | 0 | SEC↗ |
| UPB Upstream Bio, Inc. | C Conversion deriv | 2024-10-15 | 2024-10-17 | 2,098,000 | — | $0 | 0 | SEC↗ |
| UPB Upstream Bio, Inc. | C Conversion deriv | 2024-10-15 | 2024-10-17 | 197,456 | — | $0 | 0 | SEC↗ |
| UPB Upstream Bio, Inc. | C Conversion deriv | 2024-10-15 | 2024-10-17 | 789,833 | — | $0 | 0 | SEC↗ |
| UPB Upstream Bio, Inc. | P Buy | 2024-10-15 | 2024-10-17 | 660,000 | $17.00 | $11.22M | 4,554,873 | SEC↗ |
| UPB Upstream Bio, Inc. | C Conversion | 2024-10-15 | 2024-10-17 | 721,956 | — | $0 | 973,716 | SEC↗ |
| UPB Upstream Bio, Inc. | P Buy | 2024-10-15 | 2024-10-17 | 165,000 | $17.00 | $2.81M | 1,138,716 | SEC↗ |
| UPB Upstream Bio, Inc. | C Conversion | 2024-10-15 | 2024-10-17 | 2,887,833 | — | $0 | 3,894,873 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 1,841,100 | $2.40 | $4.42M | 7,526,359 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 1,041,700 | $2.40 | $2.50M | 1,255,985 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 242,200 | $2.40 | $581.3K | 990,254 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-08-15 | 2023-08-17 | 248,819 | $0.75 | $186.6K | 631,048 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-08-15 | 2023-08-17 | 38,327 | $0.75 | $28.7K | 97,204 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-08-15 | 2023-08-17 | 535,534 | $0.75 | $401.7K | 1,510,375 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-31 | 2023-08-02 | 153,078 | $3.00 | $459.2K | 2,105,909 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-31 | 2023-08-02 | 29,700 | $3.00 | $89.1K | 879,867 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-31 | 2023-08-02 | 26,622 | $3.00 | $79.9K | 135,531 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-25 | 2023-07-27 | 4,700 | $2.92 | $13.7K | 909,567 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-25 | 2023-07-27 | 7,800 | $2.92 | $22.8K | 162,153 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-25 | 2023-07-27 | 26,700 | $2.92 | $78.0K | 2,258,987 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-13 | 2023-07-17 | 52,800 | $2.40 | $126.7K | 914,267 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-13 | 2023-07-17 | 132,100 | $2.40 | $317.0K | 2,285,687 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-07-13 | 2023-07-17 | 9,800 | $2.40 | $23.5K | 169,953 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 125,000 | $2.09 | $261.2K | 1,027,885 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 250,000 | $2.09 | $522.5K | 646,657 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 442,000 | $2.09 | $923.8K | 5,685,259 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 58,000 | $2.09 | $121.2K | 748,054 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-17 | 2023-04-17 | 660 | $1.97 | $1.3K | 179,753 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-17 | 2023-04-17 | 8,878 | $1.97 | $17.5K | 2,417,787 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-17 | 2023-04-17 | 3,551 | $1.97 | $7.0K | 967,067 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-14 | 2023-04-17 | 28,110 | $1.86 | $52.3K | 2,426,665 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-14 | 2023-04-17 | 11,245 | $1.86 | $20.9K | 970,618 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-14 | 2023-04-17 | 2,091 | $1.86 | $3.9K | 180,413 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-13 | 2023-04-17 | 703 | $1.82 | $1.3K | 182,504 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-13 | 2023-04-17 | 3,784 | $1.82 | $6.9K | 981,863 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-13 | 2023-04-17 | 9,459 | $1.82 | $17.2K | 2,454,775 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-12 | 2023-04-12 | 641 | $1.81 | $1.2K | 985,647 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-12 | 2023-04-12 | 119 | $1.81 | $215 | 183,207 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-12 | 2023-04-12 | 1,603 | $1.81 | $2.9K | 2,464,234 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-11 | 2023-04-12 | 3,784 | $1.82 | $6.9K | 986,288 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-11 | 2023-04-12 | 703 | $1.82 | $1.3K | 183,326 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-11 | 2023-04-12 | 9,459 | $1.82 | $17.2K | 2,465,837 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-10 | 2023-04-12 | 34,745 | $1.79 | $62.2K | 2,500,582 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-10 | 2023-04-12 | 13,899 | $1.79 | $24.9K | 1,000,187 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-10 | 2023-04-12 | 2,584 | $1.79 | $4.6K | 185,910 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-06 | 2023-04-07 | 487 | $2.00 | $974 | 186,613 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-06 | 2023-04-07 | 2,620 | $2.00 | $5.2K | 1,003,971 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-06 | 2023-04-07 | 6,558 | $2.00 | $13.1K | 2,510,041 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-05 | 2023-04-07 | 4,687 | $2.18 | $10.2K | 187,100 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-05 | 2023-04-07 | 63,058 | $2.18 | $137.5K | 2,516,599 | SEC↗ |
| GLTO Galecto, Inc. | S Sale | 2023-04-05 | 2023-04-07 | 25,220 | $2.18 | $55.0K | 1,006,591 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2022-01-26 | 2022-01-27 | 10,740 | $8.38 | $90.0K | 1,829,436 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2022-01-26 | 2022-01-27 | 10,742 | $8.38 | $90.0K | 1,829,433 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2022-01-25 | 2022-01-27 | 24,546 | $8.40 | $206.2K | 1,840,175 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2022-01-25 | 2022-01-27 | 24,545 | $8.40 | $206.2K | 1,840,176 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-12-10 | 2021-12-14 | 214,285 | $14.00 | $3.00M | 242,285 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-02-12 | 2021-02-18 | 420,299 | $13.00 | $5.46M | 5,243,259 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-02-12 | 2021-02-18 | 104,050 | $13.00 | $1.35M | 396,657 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion deriv | 2020-11-02 | 2020-11-04 | 116,800 | — | $0 | 0 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion deriv | 2020-11-02 | 2020-11-04 | 272,533 | — | $0 | 0 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion deriv | 2020-11-02 | 2020-11-04 | 109,013 | — | $0 | 0 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion deriv | 2020-11-02 | 2020-11-04 | 77,866 | — | $0 | 0 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion deriv | 2020-11-02 | 2020-11-04 | 31,147 | — | $0 | 0 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion deriv | 2020-11-02 | 2020-11-04 | 148,395 | — | $0 | 0 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion deriv | 2020-11-02 | 2020-11-04 | 59,350 | — | $0 | 0 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion deriv | 2020-11-02 | 2020-11-04 | 73,773 | — | $0 | 0 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion deriv | 2020-11-02 | 2020-11-04 | 291,999 | — | $0 | 0 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion | 2020-11-02 | 2020-11-04 | 2,055,824 | — | $0 | 2,055,824 | SEC↗ |
| GLTO Galecto, Inc. | P Buy | 2020-11-02 | 2020-11-04 | 209,500 | $15.00 | $3.14M | 1,031,811 | SEC↗ |
| GLTO Galecto, Inc. | P Buy | 2020-11-02 | 2020-11-04 | 523,833 | $15.00 | $7.86M | 2,579,657 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion | 2020-11-02 | 2020-11-04 | 191,787 | — | $0 | 191,787 | SEC↗ |
| GLTO Galecto, Inc. | C Conversion | 2020-11-02 | 2020-11-04 | 822,311 | — | $0 | 822,311 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | P Buy | 2020-10-01 | 2020-10-05 | 545,974 | $6.00 | $3.28M | 3,524,997 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | P Buy | 2020-10-01 | 2020-10-05 | 296,296 | $6.00 | $1.78M | 296,296 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | P Buy | 2020-10-01 | 2020-10-05 | 639,212 | $6.00 | $3.84M | 4,126,972 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2020-09-25 | 2020-11-04 | 59,350 | $27.11 | $1.61M | 59,350 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2020-09-25 | 2020-11-04 | 148,395 | $27.11 | $4.02M | 148,395 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2020-09-25 | 2020-11-04 | 73,773 | $27.11 | $2.00M | 73,773 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2020-09-21 | 2020-09-23 | 137,500 | $28.00 | $3.85M | 1,864,721 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2020-09-21 | 2020-09-23 | 137,500 | $28.00 | $3.85M | 1,864,721 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2020-09-17 | 2020-09-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2020-09-17 | 2020-09-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 292,607 | — | $0 | 292,607 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 902,885 | — | $0 | 902,855 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 4,822,960 | — | $0 | 4,822,960 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 7,944,444 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 7,944,444 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 1,277,858 | — | $0 | 2,002,221 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 1,277,858 | — | $0 | 2,002,221 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2019-11-11 | 2019-11-13 | 418,750 | $16.00 | $6.70M | 724,363 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2019-11-11 | 2019-11-13 | 418,750 | $16.00 | $6.70M | 724,363 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | C Conversion deriv | 2018-10-23 | 2018-10-25 | 2,678,571 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | C Conversion deriv | 2018-10-23 | 2018-10-25 | 3,046,943 | — | $0 | 2,279,023 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | C Conversion deriv | 2018-10-23 | 2018-10-25 | 4,352,775 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | C Conversion | 2018-10-23 | 2018-10-25 | 2,279,023 | — | $0 | 5,276,783 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | C Conversion | 2018-10-23 | 2018-10-25 | 2,997,760 | — | $0 | 2,997,760 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | P Buy | 2018-10-23 | 2018-10-25 | 490,000 | $10.00 | $4.90M | 5,766,783 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | P Buy | 2018-10-23 | 2018-10-25 | 700,000 | $10.00 | $7.00M | 6,466,783 | SEC↗ |
| STDY SteadyMed Ltd. | S Sale deriv | 2018-08-30 | 2018-09-07 | 0 | — | $0 | 0 | SEC↗ |
| STDY SteadyMed Ltd. | P Buy deriv | 2018-08-30 | 2018-09-07 | 55,000 | $3.85 | $211.8K | 348,500 | SEC↗ |
| STDY SteadyMed Ltd. | S Sale deriv | 2018-08-30 | 2018-09-07 | 1,536,098 | — | $0 | 0 | SEC↗ |
| STDY SteadyMed Ltd. | S Sale deriv | 2018-08-30 | 2018-09-07 | 348,500 | — | $0 | 0 | SEC↗ |
| STDY SteadyMed Ltd. | P Buy deriv | 2018-08-30 | 2018-09-07 | 55,000 | $3.85 | $211.8K | 348,500 | SEC↗ |
| STDY SteadyMed Ltd. | S Sale deriv | 2018-08-30 | 2018-09-07 | 348,500 | — | $0 | 0 | SEC↗ |
| STDY SteadyMed Ltd. | S Sale | 2018-08-30 | 2018-09-07 | 2,123,098 | $4.46 | $9.47M | 0 | SEC↗ |
| STDY SteadyMed Ltd. | S Sale | 2018-08-30 | 2018-09-07 | 2,123,098 | $4.46 | $9.47M | 0 | SEC↗ |
| STDY SteadyMed Ltd. | P Buy deriv | 2017-04-25 | 2017-04-27 | 293,500 | $0.13 | $38.2K | 293,500 | SEC↗ |
| STDY SteadyMed Ltd. | P Buy deriv | 2017-04-25 | 2017-04-27 | 293,500 | $0.13 | $38.2K | 293,500 | SEC↗ |
| STDY SteadyMed Ltd. | P Buy | 2017-04-25 | 2017-04-27 | 587,000 | $5.90 | $3.46M | 2,123,098 | SEC↗ |
| STDY SteadyMed Ltd. | P Buy | 2017-04-25 | 2017-04-27 | 587,000 | $5.90 | $3.46M | 2,123,098 | SEC↗ |